Bioorganic & Medicinal Chemistry Letters最新文献

筛选
英文 中文
Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effect
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130044
Shuhua Ren , Fengling Liu , Man Chi , Jinfeng Liu , Yi Huang , Weiwei Huang , Wenjing Gu , Yaxia Yuan , Shurong Hou , Xiabin Chen , Lei Ma
{"title":"Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effect","authors":"Shuhua Ren ,&nbsp;Fengling Liu ,&nbsp;Man Chi ,&nbsp;Jinfeng Liu ,&nbsp;Yi Huang ,&nbsp;Weiwei Huang ,&nbsp;Wenjing Gu ,&nbsp;Yaxia Yuan ,&nbsp;Shurong Hou ,&nbsp;Xiabin Chen ,&nbsp;Lei Ma","doi":"10.1016/j.bmcl.2024.130044","DOIUrl":"10.1016/j.bmcl.2024.130044","url":null,"abstract":"<div><div>We synthesized and evaluated a series of derivatives based on the pyrimidine-2,4-diamine scaffold as potential JNK1 inhibitors, incorporating bridging rings and spirocyclic modifications to enhance their inhibitory activity. These compounds were biologically assessed through JNK enzyme inhibition assays and Western Blot analysis. Compounds <strong>13</strong>, <strong>14</strong> and <strong>19</strong> demonstrated significant inhibitory activity at both the enzyme and cellular level compared to the lead compound <strong>1</strong> and clinical candidate <strong>CC-90001</strong>. Notably, <strong>14</strong> exhibited strong inhibitory potency against JNK1 with sub-nanomolar efficacy and suppresses TGF-β-induced epithelial-mesenchymal transition, indicating its potential as a promising candidate for further development as an anti-pulmonary fibrosis agent targeting JNK1.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130044"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142745138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brominated chalcones as promising antileishmanial agents
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130042
Tayssa S.A. Barreto , Tamiris A.C. Santos , Audrey R.S.T. Silva , Emmanoel V. Costa , Liciane A. Pinheiro , Roberta P.M. Fernandes , Ricardo Scher , Péricles B. Alves
{"title":"Brominated chalcones as promising antileishmanial agents","authors":"Tayssa S.A. Barreto ,&nbsp;Tamiris A.C. Santos ,&nbsp;Audrey R.S.T. Silva ,&nbsp;Emmanoel V. Costa ,&nbsp;Liciane A. Pinheiro ,&nbsp;Roberta P.M. Fernandes ,&nbsp;Ricardo Scher ,&nbsp;Péricles B. Alves","doi":"10.1016/j.bmcl.2024.130042","DOIUrl":"10.1016/j.bmcl.2024.130042","url":null,"abstract":"<div><div>Leishmaniasis is a group of diseases caused by protozoa of the genus <em>Leishmania</em>. They are considered neglected diseases and are endemic to tropical and subtropical regions, affecting thousands of people annually. Leishmaniasis has a wide global distribution, present on four continents. Various drugs have been used to control leishmaniasis; however, obstacles such as high toxicity to patients and the occurrence of resistance have led to the search for alternatives. Chalcones are α, β-unsaturated ketones that can occur in the secondary metabolism of plants or can be obtained through organic synthesis. In this study, 21 chalcones brominated were synthesized via the Claisen-Schmidt condensation synthesis and characterized by UHRMS and NMR. The biological activity was evaluated for antiprotozoal potential against <em>Leishmania amazonensis</em> and cytotoxicity against L929 fibroblasts. Eighteen chalcones showed viability inhibition rates above 80 % at a concentration of 50 µM. Six chalcones demonstrated IC50 values ranging from 6.33 ± 0.70 µM to 23.95 ± 2.94 µM and maintained 70 % viability in L929 fibroblasts at 50 µM. The (<em>E</em>)-1-(4-bromophenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one, with a trimethoxylation at positions 2, 4, and 5 of ring B and a bromine substituent at position 4 of ring A, exhibited the lowest IC50 value (6.33 µM). These results indicate that these brominated chalcones have potential for studies aiming at the development of new drugs for leishmaniasis control.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130042"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(E)-3-(3-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones inducing reactive oxygen species generation through glutathione depletion.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130043
Youngshim Lee, Seunghyun Ahn, Euitaek Jung, Yoongho Lim, Dongsoo Koh, Dong-Ho Bae, Soon Young Shin
{"title":"(E)-3-(3-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones inducing reactive oxygen species generation through glutathione depletion.","authors":"Youngshim Lee, Seunghyun Ahn, Euitaek Jung, Yoongho Lim, Dongsoo Koh, Dong-Ho Bae, Soon Young Shin","doi":"10.1016/j.bmcl.2024.130043","DOIUrl":"https://doi.org/10.1016/j.bmcl.2024.130043","url":null,"abstract":"<p><p>The accumulation of reactive oxygen species (ROS) disrupts reduction-oxidation homeostasis, which can result in damage to cancer cells. To identify the compounds generating ROS, compounds containing Michael acceptors were designed because they are suggested to be critical for ROS elevation via glutathione depletion. Twelve (E)-3-(3-([1,1'-biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones were synthesized and identified using nuclear magnetic resonance spectroscopy and mass spectrometry. Intracellular ROS levels induced by treatment with the compounds were determined using fluorescence microscopy with the oxidant-sensing fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate. We selected compound 9, which showed the highest activity, and performed further biological experiments, including glutathione depletion and apoptosis assays, using MIA PaCa-2 pancreatic cancer cells. Additionally, the reason why the intracellular ROS level by compound 9 was lower than that of menadione used as a control was explained through in silico docking experiments. Our findings suggest that compound 9 has the potential to act as an anticancer agent by inducing ROS generation through the depletion of intracellular glutathione.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130043"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, X-ray studies and antiproliferative activity of novel lasalocid amides. 新型 lasalocid 酰胺的合成、X 射线研究和抗增殖活性。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-25 DOI: 10.1016/j.bmcl.2024.130041
Michał Sulik, Zbigniew Kubis, Dagmara Kłopotowska, Jan Janczak, Joanna Wietrzyk, Adam Huczyński
{"title":"Synthesis, X-ray studies and antiproliferative activity of novel lasalocid amides.","authors":"Michał Sulik, Zbigniew Kubis, Dagmara Kłopotowska, Jan Janczak, Joanna Wietrzyk, Adam Huczyński","doi":"10.1016/j.bmcl.2024.130041","DOIUrl":"https://doi.org/10.1016/j.bmcl.2024.130041","url":null,"abstract":"<p><p>Seeking new drug candidates among compounds of natural origin is an effective and widely used method of fighting various diseases, especially cancer. Lasalocid acid is one of the naturally occurring polyether ionophore antibiotics, which also exhibits interesting anticancer activity. Therefore, to expand the knowledge about the anticancer properties of lasalocid derivatives, a series of its new amides were synthesized and their antiproliferative activity against cancer cell lines was studied. Amides 7-9 with an aromatic substituent, displayed potent antiproliferative activity (IC<sub>50</sub>: 0.84-5.18 μM) and demonstrated a good selectivity index (SI: 1.4-15.3). Furthermore, almost all of lasalocid amides overcame the drug resistance of the doxorubicin-resistant cancer cell line (LoVo/DX). Because the biological activity of ionophores is strictly connected with their ability to transport the Na<sup>+</sup> cation through lipid bilayers, the crystal structure of the complex of compound 8 with the Na<sup>+</sup> cation was resolved. Lasalocid amides exhibit a pseudocyclic structure and are able to coordinate the Na<sup>+</sup> cation.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130041"},"PeriodicalIF":2.5,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142737893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of drimanyl indole fragments of drimentine alkaloids and their antibacterial activities drimanyl indole fragments of drimentine alkaloids and their antibacterial activities.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-24 DOI: 10.1016/j.bmcl.2024.130040
Jili Feng , Nini Qu , Summia Kalsoom , Zunjun Zhou , Shiyi Zhang , Zhe Cui , Chongmin Zhong , Miaofeng Ma
{"title":"Synthesis of drimanyl indole fragments of drimentine alkaloids and their antibacterial activities","authors":"Jili Feng ,&nbsp;Nini Qu ,&nbsp;Summia Kalsoom ,&nbsp;Zunjun Zhou ,&nbsp;Shiyi Zhang ,&nbsp;Zhe Cui ,&nbsp;Chongmin Zhong ,&nbsp;Miaofeng Ma","doi":"10.1016/j.bmcl.2024.130040","DOIUrl":"10.1016/j.bmcl.2024.130040","url":null,"abstract":"<div><div>Two types of drimanyl indole fragments of drimentine alkaloids were synthesized and evaluated their <em>in vitro</em> antibacterial activities using minimum inhibitory concentration. Analysis of structure–activity relationship against <em>Ralstonia solanacearum</em> revealed that fragment I exhibited superior inhibitory activity compared to fragment II. Notably, free N<img>H of the indole motif was essential for antibacterial activity, while C<sup>12</sup><img>OH of the drimane skeleton was beneficial for enhancing the inhibitory effect. Compound <strong>2</strong>, possessing these structural features, showed the highest activity to <em>R</em>. <em>solanacearum</em> among all the tested compounds with a MIC value of 8 µg/mL, indicating its potential as a promising lead for the development of novel antibiotics.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130040"},"PeriodicalIF":2.5,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, synthesis and biological evaluation of alginate oligosaccharide derivatives 海藻酸寡糖衍生物的设计、合成和生物学评价。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-23 DOI: 10.1016/j.bmcl.2024.130039
Wenkang Guo , Manchun Chen , Changjie Zou , Weizhi Liu , Weidong Wang , Heyong Gao
{"title":"Design, synthesis and biological evaluation of alginate oligosaccharide derivatives","authors":"Wenkang Guo ,&nbsp;Manchun Chen ,&nbsp;Changjie Zou ,&nbsp;Weizhi Liu ,&nbsp;Weidong Wang ,&nbsp;Heyong Gao","doi":"10.1016/j.bmcl.2024.130039","DOIUrl":"10.1016/j.bmcl.2024.130039","url":null,"abstract":"<div><div>To discover new potential drug for acute kidney injury (AKI), a series of novel alginate oligosaccharide derivatives were synthesized and characterized by the spectroscopic analysis. By using the controlled experimental method, the target compounds were evaluated preliminarily for therapeutic activity in AKI. The results demonstrated that compounds <strong>2a</strong>, <strong>2b</strong>, <strong>2c</strong> and <strong>3b</strong> exhibited notable inhibitory activity against the expression of related proteins at 250 μg/ml in vitro. Furthermore, the in vivo activity of <strong>2a</strong> and <strong>2b</strong> was found to be comparable to that of the trisaccharide (AOSC).</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130039"},"PeriodicalIF":2.5,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances of selenized tubulin inhibitors in cancer therapy 硒化微管蛋白抑制剂在癌症治疗中的最新进展。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-22 DOI: 10.1016/j.bmcl.2024.130037
Yong-Chang Zhao , Liang-Qing Yan , Yuan Xu
{"title":"Recent advances of selenized tubulin inhibitors in cancer therapy","authors":"Yong-Chang Zhao ,&nbsp;Liang-Qing Yan ,&nbsp;Yuan Xu","doi":"10.1016/j.bmcl.2024.130037","DOIUrl":"10.1016/j.bmcl.2024.130037","url":null,"abstract":"<div><div>Cancer treatment always a huge challenge amidst the resistance and relapse caused by the various treatments. Inhibitors targeting mitosis have been considered as promising therapeutic drugs in clinic, of which tubulins play an important role. Selenium (Se) as an essential microelement in humans and animals, playing a crucial role in the formation of anti-oxidase (glutathione peroxidase) and selenoprotein, also attracted broad attention in cancer therapy. Because the introduction of Se atom could change the length and angle of chemical bond and alter their functional properties, regulating selenized chemotherapeutics has become one of the hot spots. However, little attention has been paid to studying the combination of Se and tubulin inhibitors. Herein, we review the latest research results of selenized tubulin inhibitors in cancer therapy, including its mechanisms, categories and biological activities, providing a theoretical basis for different selenized microtubules inhibitors therapies.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130037"},"PeriodicalIF":2.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7 发现新型环戊烷羧酸作为 NaV1.7 的强效选择性抑制剂。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-22 DOI: 10.1016/j.bmcl.2024.130033
Shaoyi Sun , Sultan Chowdhury , Ivan Hemeon , Abid Hasan , Michael S. Wilson , Phillipe Bergeron , Qi Jia , Alla Y. Zenova , Mike E. Grimwood , Wei Gong , Shannon M. Decker , Paul Bichler , Jean-Christophe Andrez , Thilo Focken , Theresa Ngyuen , Jiuxiang Zhu , Andrew D. White , Girish Bankar , Sarah Howard , Elaine Chang , Christoph M. Dehnhardt
{"title":"Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7","authors":"Shaoyi Sun ,&nbsp;Sultan Chowdhury ,&nbsp;Ivan Hemeon ,&nbsp;Abid Hasan ,&nbsp;Michael S. Wilson ,&nbsp;Phillipe Bergeron ,&nbsp;Qi Jia ,&nbsp;Alla Y. Zenova ,&nbsp;Mike E. Grimwood ,&nbsp;Wei Gong ,&nbsp;Shannon M. Decker ,&nbsp;Paul Bichler ,&nbsp;Jean-Christophe Andrez ,&nbsp;Thilo Focken ,&nbsp;Theresa Ngyuen ,&nbsp;Jiuxiang Zhu ,&nbsp;Andrew D. White ,&nbsp;Girish Bankar ,&nbsp;Sarah Howard ,&nbsp;Elaine Chang ,&nbsp;Christoph M. Dehnhardt","doi":"10.1016/j.bmcl.2024.130033","DOIUrl":"10.1016/j.bmcl.2024.130033","url":null,"abstract":"<div><div>Discovery efforts leading to the identification of cyclopentane carboxylic acid <strong>31</strong>, a potent inhibitor of Na<sub>V</sub>1.7 that showed high selectivity over Na<sub>V</sub>1.5 and exhibited robust analgesic effects in an inherited erythromelalgia (IEM) transgenic mouse assay, are described herein. Key design elements that culminated in the discovery of <strong>31</strong> include exploration of proline substituents, replacement of the proline warhead with cyclopentane carboxylic acid, that led to significantly boosted Na<sub>V</sub>1.7 potency, and replacement of the metabolically labile adamantane motif with the 2,6-dichlorobenzyl substituted piperidine system, that addressed metabolic instability and led to a significant improvement in PK.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130033"},"PeriodicalIF":2.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142694886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury 肉桂酸衍生物的设计、合成和生物活性评估,作为抗 LPS 诱导的急性肺损伤的潜在抗炎剂。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-22 DOI: 10.1016/j.bmcl.2024.130036
Pengqin Chen , Pan Chen , Xiemin Wang
{"title":"Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury","authors":"Pengqin Chen ,&nbsp;Pan Chen ,&nbsp;Xiemin Wang","doi":"10.1016/j.bmcl.2024.130036","DOIUrl":"10.1016/j.bmcl.2024.130036","url":null,"abstract":"<div><div>Acute lung injury (ALI), a common critical disease in clinical practice, has a mortality rate as high as 30–40 %, yet currently, no effective treatment methods are available. Research on ALI indicated that inhibition of overexpressed inflammatory factors might be a potential treatment for ALI. In this study, a series of cinnamic acid derivatives were obtained by introducing diverse aminothiazole fragments into the natural product cinnamic acid. Among these derivatives, compound <strong>22</strong> displayed excellent activity of inhibiting the release of IL-6 in J774A.1 cells. Moreover, it also ameliorated the LPS-induced ALI in mouse model by suppressing cytokine expression, reducing lung edema and macrophage infiltration. These findings indicated that compound <strong>22</strong> might provide a new lead structure for the development of drugs for ALI.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130036"},"PeriodicalIF":2.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142694972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs 奥司他韦类似物的合成和抗贾第虫活性评估。
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-21 DOI: 10.1016/j.bmcl.2024.130035
Harrison W. VanKoten , Breanna C. Pence , James R. Klinkenberg , Siddhartha Das , Steven E. Patterson
{"title":"Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs","authors":"Harrison W. VanKoten ,&nbsp;Breanna C. Pence ,&nbsp;James R. Klinkenberg ,&nbsp;Siddhartha Das ,&nbsp;Steven E. Patterson","doi":"10.1016/j.bmcl.2024.130035","DOIUrl":"10.1016/j.bmcl.2024.130035","url":null,"abstract":"<div><div>We reported earlier that oseltamivir (Osm, Tamiflu®), an anti-viral agent, inhibits the attachment of trophozoites to intestinal epithelial cells and cyst production in culture. Osm also disassembles lipid rafts (LRs) and the biogenesis of extracellular vesicles (EVs) by Giardia. In the current study, we synthesized forty-one Osm analogs with the derivatization of oseltamivir phosphate. These compounds were tested on giardial growth, and cyst production. Of these, four analogs, i.e., compounds <strong>3b</strong>, <strong>2c</strong>, <strong>11i</strong>, and <strong>11d</strong>, were found to have superior activities against trophozoites and cysts compared to the parent oseltamivir. Investigation of the mechanism(s) of action of these agents are in progress and will be reported in due course.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130035"},"PeriodicalIF":2.5,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142692200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信